Cas No.: 1332850-08-4
PRODUCT INFORMATION
Description
Breast cancer-targeting peptide 18-4 (WxEAAYQrFL) is a KRT1 receptor-specific ligand with a reported Kd of ~1.1 μM. This proteolytically stable analogue of the P160 peptide enables precise targeting through KRT1-mediated internalization in research models. It has been shown to enhance cellular uptake and exhibits in vitro cytotoxic activity when covalently conjugated with agents like MccJ25.
Molecular Weight
1296.47
Purity
> 95%
Formula
C₆₃H₈₉N₁₅O₁₅
Product Type
Targeting Peptide
Sequence
Trp-D-Nle-Glu-Ala-Ala-Tyr-Gln-D-Arg-Phe-Leu
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- CGGK Targeting Peptide (CAT#: OLY-1025-YS-27)
- P160 Targeting Peptide (CAT#: OLY-1025-YS-21)
- IRGD Peptide 1 TFA (CAT#: OLY-1025-YS-58)
- LinTT1 Targeting Peptide (CAT#: OLY-1025-YS-24)
- NBD-LLLLpY Targeting Peptide (CAT#: OLY-1025-YS-50)
- Osteocalcin (1-49) (human) Targeting Peptide (CAT#: OLY-1025-YS-9)
- 293P-1 Targeting Peptide (CAT#: OLY-1025-YS-17)
- FRα-targeting Peptide C7 (CAT#: OLY-1025-YS-13)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.